Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vaxart, Inc.VXRT · Entity 6654 | Director | July 16, 2026 | July 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vaxart, Inc.
Report date July 16, 2026 · Filed July 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 244,171 |
Reported balance
After 2026-07-16 transaction · row 1
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 39,400 · Balance 244,171 F1: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2036-07-16 | Direct | 78,700 |
Reported balance
After 2026-07-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-16 · Grant · Acquired 78,700 · Balance 78,700 F2: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant.
F2: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2026 Filed Jul 20, 2026 20:04 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantStock Options (right to buy) · Derivative | 78,700 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001437749-26-023863 · rdgdoc.xml · derivative · entry 2 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,700 Underlying: Common Stock · 78,700 shares Expires 2036-07-16 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 20:04 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantCommon Stock | 39,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-023863 · rdgdoc.xml · nonDerivative · entry 1 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,171 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 20:06 UTC | Vaxart, Inc. VXRT · Entity 6654 | PurchaseCommon Stock | 50,000 | $0.37 | $18,500.00 |
DisclosureSEC source: 0001437749-25-027356 · rdgdoc.xml · nonDerivative · entry 6 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,771 Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 20:06 UTC | Vaxart, Inc. VXRT · Entity 6654 | PurchaseCommon Stock | 50,000 | $0.35 | $17,500.00 |
DisclosureSEC source: 0001437749-25-027356 · rdgdoc.xml · nonDerivative · entry 5 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,771 Read SEC document |
| July 30, 2025 Filed Aug 19, 2025 20:06 UTC | Vaxart, Inc. VXRT · Entity 6654 | PurchaseCommon Stock | 25,874 | $0.38 | $9,832.12 |
DisclosureSEC source: 0001437749-25-027356 · rdgdoc.xml · nonDerivative · entry 4 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,771 F1 · date: This transaction is being reported late due to an administrative oversight. Read SEC document |
| July 28, 2025 Filed Aug 19, 2025 20:06 UTC | Vaxart, Inc. VXRT · Entity 6654 | PurchaseCommon Stock | 20,000 | $0.40 | $8,000.00 |
DisclosureSEC source: 0001437749-25-027356 · rdgdoc.xml · nonDerivative · entry 3 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,897 F1 · date: This transaction is being reported late due to an administrative oversight. Read SEC document |
| July 25, 2025 Filed Aug 19, 2025 20:06 UTC | Vaxart, Inc. VXRT · Entity 6654 | PurchaseCommon Stock | 20,000 | $0.39 | $7,800.00 |
DisclosureSEC source: 0001437749-25-027356 · rdgdoc.xml · nonDerivative · entry 2 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,897 F1 · date: This transaction is being reported late due to an administrative oversight. Read SEC document |
| July 17, 2025 Filed Aug 19, 2025 20:06 UTC | Vaxart, Inc. VXRT · Entity 6654 | PurchaseCommon Stock | 794 | $0.38 | $301.72 |
DisclosureSEC source: 0001437749-25-027356 · rdgdoc.xml · nonDerivative · entry 1 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,897 F1 · date: This transaction is being reported late due to an administrative oversight. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:06 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantStock Option (right to buy) · Derivative | 36,392 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001437749-25-020572 · rdgdoc.xml · derivative · entry 2 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,392 Underlying: Common Stock · 36,392 shares Expires 2035-06-13 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary of the date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:06 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantCommon Stock | 6,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020572 · rdgdoc.xml · nonDerivative · entry 1 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,103 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary date of the grant. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 01:05 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantStock Option (right to buy) · Derivative | 190,800 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-25-002175 · rdgdoc.xml · derivative · entry 2 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,800 Underlying: Common Stock · 190,800 shares Expires 2035-01-28 F2 · derivative.exercise_date: The shares subject to this option shall vest annually over three years from the vesting commencement date of January 28, 2025, the date of the grantee's appointment as a director of Vaxart, Inc. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 01:05 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002175 · rdgdoc.xml · nonDerivative · entry 1 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 F1 · shares: Grant of shares upon vesting of restricted stock units. One third of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the third anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.